首页/数据集/Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking

Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking

NCATS Open Data2023-04-14 更新2026-08-08 收录

新冠变异株中和抗体

构象锁定抗体设计

数据链接：

https://doi.org/10.1101/2023.04.08.536123 数据链接链接失效反馈

官方服务：

资源简介：

Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking

应用场景：

创建时间：

2023-04-10

新冠变异株中和抗体

免疫效果评估

Comparable neutralization of SARS-CoV-2 Delta AY.1 and delta in individuals sera vaccinated with BBV152

NCATS Open Data2021-10-01 更新10

Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers

新冠变异株中和抗体

长期护理院免疫应答

Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers

NCATS Open Data2021-09-10 更新00

SARS-CoV-2 BA.4/5 Spike recognition and neutralization elicited after the third dose of mRNA vaccine

新冠变异株中和抗体

mRNA疫苗免疫反应

SARS-CoV-2 BA.4/5 Spike recognition and neutralization elicited after the third dose of mRNA vaccine

NCATS Open Data2022-08-19 更新00

DataSheet_1_Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.docx

新冠变异株中和抗体

马抗血清药物开发

The COVID-19 pandemic caused by the severe acute syndrome virus 2 (SARS-CoV-2) has been around since November 2019. As of early June 2022, more than 527 million cases were diagnosed, with more than 6.

NIAID Data Ecosystem10

Convalescent-phase sera and vaccine-elicited antibodies largely maintain neutraliing titer against global SARS-CoV-2 variant spikes

新冠变异株中和抗体

疫苗免疫评估

Convalescent-phase sera and vaccine-elicited antibodies largely maintain neutraliing titer against global SARS-CoV-2 variant spikes

NCATS Open Data2021-06-25 更新00

Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking

资源简介：

相关数据集